Clonazepam Tablet
Product Images NDC 71610-852

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 71610-852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0852 12)

Clonazepam USP 1 mg tablets, 12 count package label showing the product name, strength, NDC 71610-852-12, manufacturer Aphena Pharma Solutions - Tennessee, LLC, and storage instructions. It includes a warning to keep out of reach of children and notes the product as a Schedule IV controlled substance. The label also provides batch and expiration details.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Clonazepam Str)

Chemical structure of Clonazepam, a benzodiazepine derivative characterized by a fused benzodiazepine ring system with nitro and chlorine substituents visible in the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.